Effects of Transcutaneous Acupoint Electrical Stimulation on Intestinal Obstruction After Gastrointestinal Surgery

NCT03086304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 610

Last updated 2019-11-19

No results posted yet for this study

Summary

Postoperative intestinal obstruction (POI) is one of the most common complications in the gastrointestinal surgery. Compared with the conventional control group, transcutaneous acupoint electrical stimulation(TEAS) is possible to reduce the incidence of POI and accelerate the rapid recovery of the gastrointestinal tract.

Conditions

  • Postoperative Intestinal Obstruction

Interventions

DEVICE

transcutaneous acupoint electrical stimulation

Transcutaneous acupoint electrical stimulation is same to the traditional Chinese medicine acupuncture treatment,treat diseases by stimulate different acupuncture points.

DEVICE

no transcutaneous acupoint electrical stimulation

the choice of acupoints are same with TEAS group,tape over the electrode but don't give electroacupuncture stimulation.

Sponsors & Collaborators

  • Shaanxi Provincial People's Hospital

    collaborator OTHER
  • Xi'an Central Hospital

    collaborator OTHER
  • Ankang Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Affiliated Hospital of Shaanxi University of traditional Chinese Medicine

    collaborator UNKNOWN
  • Ankang Central Hospital

    collaborator OTHER
  • Weinan Central Hospital

    collaborator OTHER
  • Central Railway Group of Xi'an Central Hospital

    collaborator UNKNOWN
  • Xi'an Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Yan'an University Affiliated Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Qiang Wang, PHD · First Affiliated Hospital of Xian JiaotongUniversity

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-28
Primary Completion
2019-09-03
Completion
2019-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03086304 on ClinicalTrials.gov